switched from semaglutide to tirzepatide Switching semaglutide: complete transition guide transitioning from semaglutide to tirzepatide

Retatrutide is a next-generation research peptide being studied for its interaction with multiple metabolic receptor pathways, including GLP-1, GIP, and glucagon signaling systems

Local pathways may vary

The choice between the two medications may depend on individual patient preferences and tolerability to specific side effects

You can also apply watermelon juice to your skin to enjoy a dewy complexion

Last year, a study revealed people with diabetes who use the drugs could face double the risk of developing age-related macular degeneration, while reports based on adverse event reporting systems and matched cohort studies have suggested some GLP-1 medications have the potential to cause an eye disorder called non-arteritic anterior ischaemic optic neuropathy